IF staining confirmed highest expression of immune checkpoints PD-L1 on TRIM21 overexpression tumors in comparison to other groups, indicating TRIM21 could promote tumor immunogenicity in pancreatic cancer (Fig. 7D, E). This evidence concerns the gene TRIM21 and pancreatic neoplasm.